Catharanthine alkaloids are noncompetitive antagonists of muscle-type nicotinic acetylcholine receptors

Hugo R. Arias, Dominik Feuerbach, Katarzyna M. Targowska-Duda, Krzysztof Jozwiak

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

We compared the interaction of several catharanthine alkaloids including, ibogaine, vincristine, and vinblastine, with that for the noncompetitive antagonist phencyclidine (PCP) at muscle nicotinic acetylcholine receptors (AChRs) in different conformational states. The results established that catharanthine alkaloids: (a) inhibit, in a noncompetitive manner, (±)-epibatidine-induced Ca2+ influx in TE671-hα1β1γδ cells with similar potencies (IC50=17-25μM), (b) inhibit [3H]TCP binding to the desensitized Torpedo AChR with higher affinity compared to the resting AChR, and (c) enhance [3H]cytisine binding to resting but activatable Torpedo AChRs, suggesting desensitizing properties. Interestingly, PCP inhibits [3H]ibogaine binding to the AChR in a steric fashion. This is corroborated by additional docking experiments indicating that the amino groups of neutral ibogaine form hydrogen bonds with the serine ring (position 6'), a location shared with PCP. Since protonated ibogaine forms a salt bridge with one of the acidic residues at the outer ring (position 20'), this ligand could be first attracted to the entrance of the channel by electrostatic interactions. Our data indicate that the catharanthine moiety is a minimum structural requirement for AChR inhibition including, ion channel blocking and desensitization, and that ibogaine and PCP bind to overlapping sites in the desensitized AChR ion channel.

Original languageEnglish
Pages (from-to)153-161
Number of pages9
JournalNeurochemistry International
Volume57
Issue number2
DOIs
StatePublished - 1 Sep 2010
Externally publishedYes

Fingerprint

Ibogaine
Nicotinic Receptors
Cholinergic Receptors
Alkaloids
Muscles
Torpedo
epibatidine
Ion Channels
Phencyclidine
Vinblastine
Vincristine
Static Electricity
Serine
Inhibitory Concentration 50
catharanthine
Hydrogen
Salts
Ligands

Keywords

  • Ca influx
  • Catharanthine alkaloids
  • Ibogaine
  • Molecular modeling
  • Nicotinic acetylcholine receptors
  • Noncompetitive antagonists
  • Nonformational states
  • Vinca alkaloids

Cite this

Arias, Hugo R. ; Feuerbach, Dominik ; Targowska-Duda, Katarzyna M. ; Jozwiak, Krzysztof. / Catharanthine alkaloids are noncompetitive antagonists of muscle-type nicotinic acetylcholine receptors. In: Neurochemistry International. 2010 ; Vol. 57, No. 2. pp. 153-161.
@article{9c4e218655fb4c92906747dfe30c2283,
title = "Catharanthine alkaloids are noncompetitive antagonists of muscle-type nicotinic acetylcholine receptors",
abstract = "We compared the interaction of several catharanthine alkaloids including, ibogaine, vincristine, and vinblastine, with that for the noncompetitive antagonist phencyclidine (PCP) at muscle nicotinic acetylcholine receptors (AChRs) in different conformational states. The results established that catharanthine alkaloids: (a) inhibit, in a noncompetitive manner, (±)-epibatidine-induced Ca2+ influx in TE671-hα1β1γδ cells with similar potencies (IC50=17-25μM), (b) inhibit [3H]TCP binding to the desensitized Torpedo AChR with higher affinity compared to the resting AChR, and (c) enhance [3H]cytisine binding to resting but activatable Torpedo AChRs, suggesting desensitizing properties. Interestingly, PCP inhibits [3H]ibogaine binding to the AChR in a steric fashion. This is corroborated by additional docking experiments indicating that the amino groups of neutral ibogaine form hydrogen bonds with the serine ring (position 6'), a location shared with PCP. Since protonated ibogaine forms a salt bridge with one of the acidic residues at the outer ring (position 20'), this ligand could be first attracted to the entrance of the channel by electrostatic interactions. Our data indicate that the catharanthine moiety is a minimum structural requirement for AChR inhibition including, ion channel blocking and desensitization, and that ibogaine and PCP bind to overlapping sites in the desensitized AChR ion channel.",
keywords = "Ca influx, Catharanthine alkaloids, Ibogaine, Molecular modeling, Nicotinic acetylcholine receptors, Noncompetitive antagonists, Nonformational states, Vinca alkaloids",
author = "Arias, {Hugo R.} and Dominik Feuerbach and Targowska-Duda, {Katarzyna M.} and Krzysztof Jozwiak",
year = "2010",
month = "9",
day = "1",
doi = "10.1016/j.neuint.2010.05.007",
language = "English",
volume = "57",
pages = "153--161",
journal = "Neurochemistry International",
issn = "0197-0186",
publisher = "Elsevier Ltd",
number = "2",

}

Catharanthine alkaloids are noncompetitive antagonists of muscle-type nicotinic acetylcholine receptors. / Arias, Hugo R.; Feuerbach, Dominik; Targowska-Duda, Katarzyna M.; Jozwiak, Krzysztof.

In: Neurochemistry International, Vol. 57, No. 2, 01.09.2010, p. 153-161.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Catharanthine alkaloids are noncompetitive antagonists of muscle-type nicotinic acetylcholine receptors

AU - Arias, Hugo R.

AU - Feuerbach, Dominik

AU - Targowska-Duda, Katarzyna M.

AU - Jozwiak, Krzysztof

PY - 2010/9/1

Y1 - 2010/9/1

N2 - We compared the interaction of several catharanthine alkaloids including, ibogaine, vincristine, and vinblastine, with that for the noncompetitive antagonist phencyclidine (PCP) at muscle nicotinic acetylcholine receptors (AChRs) in different conformational states. The results established that catharanthine alkaloids: (a) inhibit, in a noncompetitive manner, (±)-epibatidine-induced Ca2+ influx in TE671-hα1β1γδ cells with similar potencies (IC50=17-25μM), (b) inhibit [3H]TCP binding to the desensitized Torpedo AChR with higher affinity compared to the resting AChR, and (c) enhance [3H]cytisine binding to resting but activatable Torpedo AChRs, suggesting desensitizing properties. Interestingly, PCP inhibits [3H]ibogaine binding to the AChR in a steric fashion. This is corroborated by additional docking experiments indicating that the amino groups of neutral ibogaine form hydrogen bonds with the serine ring (position 6'), a location shared with PCP. Since protonated ibogaine forms a salt bridge with one of the acidic residues at the outer ring (position 20'), this ligand could be first attracted to the entrance of the channel by electrostatic interactions. Our data indicate that the catharanthine moiety is a minimum structural requirement for AChR inhibition including, ion channel blocking and desensitization, and that ibogaine and PCP bind to overlapping sites in the desensitized AChR ion channel.

AB - We compared the interaction of several catharanthine alkaloids including, ibogaine, vincristine, and vinblastine, with that for the noncompetitive antagonist phencyclidine (PCP) at muscle nicotinic acetylcholine receptors (AChRs) in different conformational states. The results established that catharanthine alkaloids: (a) inhibit, in a noncompetitive manner, (±)-epibatidine-induced Ca2+ influx in TE671-hα1β1γδ cells with similar potencies (IC50=17-25μM), (b) inhibit [3H]TCP binding to the desensitized Torpedo AChR with higher affinity compared to the resting AChR, and (c) enhance [3H]cytisine binding to resting but activatable Torpedo AChRs, suggesting desensitizing properties. Interestingly, PCP inhibits [3H]ibogaine binding to the AChR in a steric fashion. This is corroborated by additional docking experiments indicating that the amino groups of neutral ibogaine form hydrogen bonds with the serine ring (position 6'), a location shared with PCP. Since protonated ibogaine forms a salt bridge with one of the acidic residues at the outer ring (position 20'), this ligand could be first attracted to the entrance of the channel by electrostatic interactions. Our data indicate that the catharanthine moiety is a minimum structural requirement for AChR inhibition including, ion channel blocking and desensitization, and that ibogaine and PCP bind to overlapping sites in the desensitized AChR ion channel.

KW - Ca influx

KW - Catharanthine alkaloids

KW - Ibogaine

KW - Molecular modeling

KW - Nicotinic acetylcholine receptors

KW - Noncompetitive antagonists

KW - Nonformational states

KW - Vinca alkaloids

UR - http://www.scopus.com/inward/record.url?scp=77953911700&partnerID=8YFLogxK

U2 - 10.1016/j.neuint.2010.05.007

DO - 10.1016/j.neuint.2010.05.007

M3 - Article

C2 - 20493225

AN - SCOPUS:77953911700

VL - 57

SP - 153

EP - 161

JO - Neurochemistry International

JF - Neurochemistry International

SN - 0197-0186

IS - 2

ER -